Abeona Therapeutics Inc. (ABEO) Covered Calls
Abeona Therapeutics Inc. (ABEO) is a clinical-stage biopharmaceutical company focused on the development of novel cell and gene therapies for severe, life-threatening rare genetic diseases. Its lead program, pz-cel, is an autologous, engineered cell therapy designed for recessive dystrophic epidermolysis bullosa (RDEB). The company also maintains a pipeline of adeno-associated virus (AAV)-based gene therapies targeting various rare ophthalmic and genetic conditions.
You can sell covered calls on Abeona Therapeutics Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ABEO (prices last updated Mon 4:16 PM ET):
| Abeona Therapeutics Inc. (ABEO) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 5.16 | +0.31 | 5.10 | 5.15 | 1.9M | 3.9 | 0.3 |
| Covered Calls For Abeona Therapeutics Inc. (ABEO) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Mar 20 | 5 | 0.25 | 4.90 | 2.0% | 60.8% | |
| Apr 17 | 5 | 0.00 | 5.15 | -2.9% | -26.5% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Abeona Therapeutics operates as a research-intensive biotech firm dedicated to addressing high unmet medical needs in rare disease populations. Its core technology platforms include autologous cell therapy—which involves modifying a patient’s own cells to correct genetic defects—and AAV-based gene delivery systems. By focusing on these cutting-edge modalities, Abeona aims to provide durable, potentially curative treatments for patients with limited therapeutic options.
The company’s R&D strategy is concentrated on advancing its clinical pipeline toward regulatory approval and commercialization. As a clinical-stage entity, Abeona manages the complex intersection of biological research, manufacturing scale-up, and regulatory navigation, prioritizing therapies where its proprietary platforms offer a distinct efficacy or delivery advantage.
Competitive Landscape
Abeona operates in the high-risk, high-reward biotechnology sector, where it competes against both established pharmaceutical giants and specialized biotech innovators. Peer companies with active, standardized options markets that provide liquid exposure to the gene and cell therapy landscape include:
- Iovance Biotherapeutics (IOVA): A leader in tumor-infiltrating lymphocyte (TIL) cell therapies, often analyzed alongside Abeona due to shared industry focus on autologous cell-based approaches.
- Vertex Pharmaceuticals (VRTX): While much larger, it is a primary benchmark for innovation in genetic and rare disease therapeutics.
- Editas Medicine (EDIT): A competitor in the gene editing and therapy space that serves as a benchmark for the development of genetic medicines.
Strategic Outlook and Innovation
Abeona’s strategic roadmap is centered on the successful regulatory progression of its lead clinical assets. The company is focused on optimizing its manufacturing processes to ensure scalability and quality consistency—key hurdles for cell and gene therapies. Innovation efforts are directed at refining its AAV delivery platforms to enhance specificity and reduce off-target effects, aiming to maintain a pipeline capable of addressing a wider range of rare genetic conditions.
| Top 10 Open Interest For Mar 20 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | QQQ covered calls | 1. | CTMX covered calls | |
| 2. | SLV covered calls | 7. | EWZ covered calls | 2. | PATH covered calls | |
| 3. | EEM covered calls | 8. | GLD covered calls | 3. | KSS covered calls | |
| 4. | SPY covered calls | 9. | FXI covered calls | 4. | OWL covered calls | |
| 5. | IBIT covered calls | 10. | KWEB covered calls | 5. | USO covered calls | |
Want more examples? ABCB Covered Calls | ABEV Covered Calls
Risk Disclosure: Trading options involves significant risk and is not suitable for all investors. The information provided on this website is for educational and informational purposes only and does not constitute financial, investment, tax, or legal advice. Nothing contained on this site is an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities or financial instruments.
Covered Call Strategy Risks: While covered call writing is often considered a conservative options strategy, it is not without risk. By selling a covered call, you are limiting your potential upside profit from the underlying stock. You remain exposed to the full downside risk of owning the underlying stock. In the event of a significant decline in the stock price, the premium received may not be sufficient to offset your losses.
No Guarantee of Performance: Past performance is not indicative of future results. Any examples, calculations, or hypothetical scenarios presented on this site are for illustrative purposes only and do not guarantee future returns or outcomes. Market conditions, liquidity, and trading system failures can affect your ability to execute trades at desired prices.
You should consult with a qualified professional advisor and conduct your own due diligence before making any investment decisions. By using this website, you acknowledge that you are responsible for your own investment decisions and agree to release this site and its affiliates from any liability relating to your use of this information. See the OCC's Characteristics and Risks of Standardized Options for more info.
